CAJ | 학술논문

目的：对出血性脑卒中再出血及其临床治疗进行分析研究。方法69例出血性脑卒中再出血患者设为研究组，同期68例非再出血患者作为对照组，观察并比较分析两组患者神经功能缺损程度、日常生活活动能力、意识障碍程度及临床疗效等。结果研究组美国国立卫生研究院卒中量表(NIHSS)、日常生活活动能力量表(ADL)得分明显高于对照组，昏迷指数(GCS)低于对照组，对照组临床治疗情况明显优于研究组，差异具有统计学意义(P<0.05)。结论临床治疗出血性脑卒中再出血应以预防为主，规范的治疗，适时手术和血压管理是防治再出血的关键。
목적：대출혈성뇌졸중재출혈급기림상치료진행분석연구。방법69례출혈성뇌졸중재출혈환자설위연구조，동기68례비재출혈환자작위대조조，관찰병비교분석량조환자신경공능결손정도、일상생활활동능력、의식장애정도급림상료효등。결과연구조미국국립위생연구원졸중량표(NIHSS)、일상생활활동능역량표(ADL)득분명현고우대조조，혼미지수(GCS)저우대조조，대조조림상치료정황명현우우연구조，차이구유통계학의의(P<0.05)。결론림상치료출혈성뇌졸중재출혈응이예방위주，규범적치료，괄시수술화혈압관리시방치재출혈적관건。
Objective To analyze and study the clinical treatment on hemorrhagic cerebral apoplexy rehaemorrhagia.Methods A total of 69 cases of patients with hemorrhagic cerebral apoplexy rehaemorrhagia were contained in research group, and 68 cases of patients without rehaemorrhagia were contained in control group. Observation and comparison was made between the two groups on the degree of nervous functional defect, ability of daily life activities, disturbance of consciousness, and clinical curative effect.Results Scores of The National Institutes of Health Stroke Scale (NIHSS) and Activity of Daily Living Scale (ADL) in the research group were obviously higher than those in the control group. Score of Glasgow Coma Scale (GCS) in the research group is lower than that in the control group. The clinical treatment of the control group is better than the research group, and the difference had statistical significance (P<0.05).Conclusion Prevention treatment is the main method in treating hemorrhagic cerebral apoplexy rehaemorrhagia, and standard treatment, timely surgery and blood pressure management are key factors in preventing rehaemorrhagia.